When Drug Reviewers Leave The FDA, They Often Work For Pharma
(By Syndney Lupkin for Kaiser Health News) More than a quarter of the Food and Drug Administration employees who approved
Read More
Senator urges FTC to step up investigation into maker of addiction treatment
(By Ed Silverman for STAT) A US senator is urging the US Federal Trade Commission to accelerate its antitrust investigation
Read MoreDoctors expect to prescribe Sarepta’s DMD drug despite insurance concerns
(By Ed Silverman for STAT) Definitive proof may be lacking that the newly approved1 Duchenne muscular dystrophy actually works, but
Read MoreThe Gap in Medigap
(By Tricia Neuman and Juliette Cubanski for Kaiser Family Foundation) Medicare provides coverage for a wide array of medical and
Read MoreVeterans’ PTSD and brain injury deserve focused research on new treatments
(By Magali Haas for STAT) Suppose that a million or more members of the US Armed Forces and veterans were
Read MoreExpert Panel Recommends Expansion Of Services With No Cost Sharing For Women
(By Michelle Andrews for Kaiser Health News) The list of preventive services that women can receive without paying anything out
Read MoreNovel cancer treatment from Kite Pharma notches positive results, but big questions remain
(By Damian Garde for STAT) A promising new approach to cancer is moving closer to reaching patients, as the biotech company Kite
Read MoreWalking Fends Off Disability, And It’s Not Too Late To Start
(By Katherine Hobson for NPR) People who have reached their later years may think it’s primarily a time to relax,
Read MoreDiabetes drugs are badly needed, but rarely make it to market
(By Ed Silverman for STAT) Diabetes 1may be a widespread disease for which millions of people need treatment, but a
Read MoreBlue Cross Blue Shield of Nebraska is Pulling Out of Obamacare
On Friday, Blue Cross Blue Shield of Nebraska announced they are pulling out of Obamacare marketplace in the state citing
Read More